Art and Science of Laboratory Medicine

Art and Science of Laboratory Medicine

Monday, June 24, 2013

Researchers Identify New Mechanism of TB Drug Resistance

Pyrazinamide (PZA) -- a frontline tuberculosis (TB) drug -- kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug-susceptible and multi-drug-resistant TB (MDR-TB) but resistance to PZA occurs frequently and can compromise treatment.

A recent study, led by researchers at the Johns Hopkins Bloomberg School of Public Health and Huashan Hospital, Fudan University, has identified a new mechanism for PZA-resistance, which provides new insight into the how this mysterious drug works. The study is available online June 12 in the journal Emerging Microbes and Infections.


Read more: 
Researchers Identify New Mechanism of TB Drug Resistance



















Source: Advanced


Art and Science of Laboratory Medicine

Twitter: LaboratoryEQAS

No comments:

Follow "Art and Science of Laboratory Medicine " on:


https://www.facebook.com/LaboratoryEQAS
https://twitter.com/LaboratoryEQAS
https://plus.google.com/100408138227362094524/posts
http://www.pinterest.com/labmed/medical-laboratory-and-biomedical-science/
http://www.linkedin.com/in/jwahlstedt
http://clinical-laboratory.blogspot.com/feeds/posts/default